Roberts Pharmaceutical
This article was originally published in The Tan Sheet
Executive Summary
Signs "two-step" agreement to acquire line of 21 Rx and OTC drugs from Glaxo Canada. The first part of the deal, which covers products purchased outright, includes five OTCs: Betnesol topical anti-inflammatory steroid, Prenavite prenatal vitamin supplement, bacitracin zinc ointment, Glaxal moisturizing cream and Barriere hand cream. Under part two of the deal, Roberts will market and promote certain Glaxo products in Canada including the Rx antihypertensive Trandate, the OTC dermatological Betnovate, and Dequadin OTC throat lozenges. Eatontown, N.J.-based Roberts said it has the option to purchase these products "subject to certain conditions".
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning